Getting your player ready...
Smokers have tried a long list of ways to quit: cold turkey, counseling, gum, patches and more.
Now, a small company is hoping it can make millions of dollars by creating a vaccine for people who want to kick the habit. Nabi Biopharmaceuticals of Rockville, Md., which is in the late stages of testing its experimental vaccine, took a big step toward its goal last week by striking a deal with pharmaceutical giant GlaxoSmithKline.
Phase 3 trials are underway.
Nabi’s experimental vaccine shuts down nicotine’s access to the brain. Smokers may light up a cigarette while on NicVax, but if the drug works as intended, they won’t feel any of the stimulating effects they crave from nicotine.
